These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 21419475

  • 1. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
    Wang XX, Zhu Z, Su D, Lei T, Wu X, Fan Y, Li X, Zhao J, Fu L, Dong JT, Fu L.
    Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
    [Abstract] [Full Text] [Related]

  • 2. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB.
    J Cell Sci; 2014 Jan 01; 127(Pt 1):85-100. PubMed ID: 24213532
    [Abstract] [Full Text] [Related]

  • 3. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH.
    J Pathol; 2012 Oct 01; 228(2):158-69. PubMed ID: 22247069
    [Abstract] [Full Text] [Related]

  • 4. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.
    Cell Signal; 2014 Dec 01; 26(12):2621-32. PubMed ID: 25152370
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K, Jiang L, Wang J, Zhang H, Wang X, Cheng D, Dou J.
    J Cancer Res Ther; 2014 Dec 01; 10(4):1063-70. PubMed ID: 25579555
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK, Norris JS.
    J Urol; 2012 Aug 01; 188(2):632-8. PubMed ID: 22704442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
    Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, Li JS.
    J Oral Pathol Med; 2014 Sep 01; 43(8):585-92. PubMed ID: 24645915
    [Abstract] [Full Text] [Related]

  • 12. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L, Jiang F, Li Y, Ye X, Mu J, Wang X, Ning S, Hu C, Li Z.
    Mol Carcinog; 2015 Sep 01; 54(9):859-69. PubMed ID: 24729530
    [Abstract] [Full Text] [Related]

  • 13. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.
    Oncogene; 2008 Jan 31; 27(6):865-76. PubMed ID: 17653090
    [Abstract] [Full Text] [Related]

  • 14. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H, Sang M, Geng C, Liu F, Gu L, Shan B.
    Neoplasma; 2016 Jan 31; 63(1):44-56. PubMed ID: 26639233
    [Abstract] [Full Text] [Related]

  • 15. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS, Hyun CL, Park IA, Kim JY, Chung YR, Im SA, Lee KH, Moon HG, Ryu HS.
    Tumour Biol; 2016 Apr 31; 37(4):4743-53. PubMed ID: 26515337
    [Abstract] [Full Text] [Related]

  • 16. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC.
    Clin Cancer Res; 2005 Aug 15; 11(16):5869-77. PubMed ID: 16115928
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.